Cours Isodiol International Inc. Canadian Securities Exchange
Actions
ISOL
CA46500L2003
Produits pharmaceutiques
CA 2018 | 19,14 M 26,34 M 17,14 M | CA 2019 | 22,25 M 30,62 M 19,92 M | Capitalisation | 49,96 M 68,76 M 44,74 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -49,55 M -32,24 M | Résultat net 2019 | -126 M -173 M -113 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 21,4 M 13,92 M | Dette nette 2019 | 5,22 M 7,19 M 4,68 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+41,50% | 6,2 Md | |
-22,89% | 4,1 Md | |
+9,36% | 3,41 Md | |
-19,39% | 2,83 Md | |
-11,05% | 2,29 Md | |
+45,24% | 1,93 Md | |
+46,81% | 1,51 Md | |
-7,51% | 1,52 Md | |
-18,04% | 1,49 Md |